Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2014 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.985 | 4 | 0 | 1983 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 1980 | 2019 | |||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
ADP ribosylation factor like GTPase 6 interacting protein 5 | 0.674 | 0.462 | 0.10 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.070 | None | 1.000 | 3 | 0 | 1997 | 2010 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
alanyl aminopeptidase, membrane | 0.462 | 0.769 | 3.7E-09 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 1991 | 2012 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
alpha 1,4-galactosyltransferase (P blood group) | 0.751 | 0.346 | 7.7E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2002 | 2019 | ||||||||
|
ankyrin repeat and KH domain containing 1 | 0.729 | 0.615 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ankyrin repeat and sterile alpha motif domain containing 1B | 0.686 | 0.423 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3C | 0.722 | 0.538 | 2.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
apoptotic peptidase activating factor 1 | 0.525 | 0.769 | 9.6E-06 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2001 | 2005 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
disease | 0.060 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
arachidonate 15-lipoxygenase | 0.502 | 0.846 | 1.1E-23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
AT-rich interaction domain 3A | 0.678 | 0.500 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.900 | strong | 1.000 | 2 | 0 | 1998 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.947 | 5 | 0 | 1986 | 2020 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2006 | 2018 |